Antifungal prophylaxis can reduce morbidity and mortality from invasive fungal disease
(IFD). However, its use needs to be optimised and appropriately targeted to patients at …

Invasive fungal disease (IFD) remains a common and serious complication in children
treated for leukaemia. Antifungal prescription in children with leukaemia presents unique …

Invasive pulmonary aspergillosis is growing in incidence, as patients at risk are growing in
diversity. Outside the classical context of neutropenia, new risk factors are emerging or …

In children with acute lymphoblastic leukemia (ALL), risk groups for invasive fungal disease
(IFD) with need for antifungal prophylaxis are not well characterized, and with the advent of …

Invasive fungal disease (IFD) is frequent in patients with haematologic malignancies and in
recipients of haematopoietic cell transplantation (HCT). An epidemiologic study conducted …

Patients with hematologic malignancies and hematopoietic cell transplant recipients (HCT)
are at high risk for invasive fungal disease (IFD). The practice of antifungal prophylaxis with …

Background Invasive fungal disease (IFD) is a significant complication for children receiving
treatment for leukaemia, contributing to morbidity and mortality. Recent regional paediatric …

Objective To obtain a national overview of the epidemiology and management of invasive
fungal infections (IFIs) in France for severely immunocompromised children who were …

Although the outcomes of childhood leukemia and severe aplastic anemia (SAA) have
improved, infectious complications are still the major concern. Particularly worrisome are …

Background Invasive fungal disease (IFD) is a common and important complication in
children with acute myeloid leukaemia (AML). We describe the epidemiology of IFD in a …